Flexcell

Flexcell International is a long-established, privately-held provider of mechanobiology research tools, operating in the medical device and cell therapy enabling technology sectors. The company's core technology platform utilizes patented vacuum pressure and pneumatic systems to apply controlled mechanical stimulation to cells, mimicking the physical forces experienced in the human body. Its products, including tension, compression, and fluid shear systems, are used by academic and industrial researchers worldwide to study disease mechanisms, engineer tissues, and improve drug screening assays. Flexcell serves as a critical enabler for advanced research but does not develop its own therapeutic drugs or diagnostics.

Patented pneumatic and vacuum-based bioreactor systems for applying computer-regulated mechanical forces (tension, compression, fluid shear stress) to cells in culture, integrated with proprietary flexible-bottom cultureware and control software.

Flexcell is a pioneer and leader in dedicated cell stretching equipment, competing with firms like CellScale and STREX. It also faces indirect competition from broader organ-on-a-chip and microphysiological system platforms (e.g., Emulate, Mimetas) that incorporate mechanical cues into more complex multi-tissue models.